Nifty

:

25377.55

Sensex

:

82948.23

-41.00 (-0.16%)
-131.43 (-0.16%)

Login

Nifty
Sensex

:
:

25377.55
82948.23

-41.00 (-0.16%)
-131.43 (-0.16%)

Orchid Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 524372 | NSE: ORCHPHARMA

Watchlist

NSE BSE

1143.55

05-Jul-2024

Open
High
Low
Previous Close

1144.00
1146.00
1125.00
1134.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

16079
183.48
1590.00
432.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,127.81
65.18
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,995.72
N/A
6.07

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-7.29
11.11
13.56

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-9.99
-
15.21

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
33.70

P:BV (Average)

8 Years
5 Years
3 Years

2.36
2.89
2.98

EV:EBITDA (Average)

8 Years
5 Years
3 Years

2.48
56.46
32.28

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 244.41 182.92 33.62% 217.10 209.90 3.43% 220.59 159.76 38.08% 198.75 165.25 20.27%
Expenses 211.16 160.78 31.33% 188.18 170.21 10.56% 184.68 146.10 26.41% 175.06 147.43 18.74%
EBITDA 33.25 22.14 50.18% 28.93 39.69 -27.11% 35.91 13.66 162.88% 23.70 17.82 33.00%
EBIDTM 13.60% 12.10% 13.32% 18.91% 16.28% 8.55% 11.92% 10.79%
Other Income 7.77 1.89 311.11% 12.88 1.73 644.51% 7.44 8.93 -16.69% 8.18 5.84 40.07%
Interest 3.47 5.54 -37.36% 3.45 7.48 -53.88% 3.54 7.68 -53.91% 3.80 9.22 -58.79%
Depreciation 8.44 7.71 9.47% 8.40 7.21 16.50% 9.27 8.18 13.33% 7.84 17.76 -55.86%
PBT 29.10 10.78 169.94% 29.96 65.93 -54.56% 30.54 6.73 353.79% 20.24 -3.32 -
Tax 0.00 0.00 0 -3.23 0.00 - 0.00 0.00 0 0.00 0.00 0
PAT 29.10 10.78 169.94% 33.19 65.93 -49.66% 30.54 6.73 353.79% 20.24 -3.32 -
PATM 11.91% 5.89% 15.29% 31.41% 13.85% 4.21% 10.18% -2.01%
EPS 5.74 2.13 169.48% 6.55 13.00 -49.62% 6.02 1.33 352.63% 3.99 -0.66 -

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 244.41 182.92 33.62% 217.10 209.90 3.43% 220.59 159.76 38.08% 198.75 165.25 20.27%
Expenses 211.91 160.78 31.80% 188.18 170.21 10.56% 185.20 146.10 26.76% 175.44 147.43 19.00%
EBITDA 32.49 22.14 46.75% 28.92 39.69 -27.14% 35.39 13.66 159.08% 23.31 17.82 30.81%
EBIDTM 13.29% 12.10% 13.32% 18.91% 16.04% 8.55% 11.73% 10.79%
Other Income 7.57 1.89 300.53% 13.36 1.73 672.25% 7.62 8.93 -14.67% 8.36 5.84 43.15%
Interest 3.50 5.54 -36.82% 3.47 7.48 -53.61% 3.54 7.68 -53.91% 3.80 9.22 -58.79%
Depreciation 8.44 7.71 9.47% 8.42 7.21 16.78% 9.27 8.18 13.33% 7.84 17.76 -55.86%
PBT 28.12 10.78 160.85% 30.38 65.93 -53.92% 30.19 6.73 348.59% 20.02 -3.32 -
Tax -0.15 0.00 - -3.12 0.00 - 0.00 0.00 0 0.00 0.00 0
PAT 28.27 10.78 162.24% 33.50 65.93 -49.19% 30.19 6.73 348.59% 20.02 -3.32 -
PATM 11.57% 5.89% 15.43% 31.41% 13.69% 4.21% 10.07% -2.01%
EPS 5.79 1.85 212.97% 6.50 14.49 -55.14% 5.80 1.86 211.83% 3.90 -1.32 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 880.85 819.37 665.90 556.97 450.69 481.21 583.65 644.17 755.36 879.34 1,736.19 Net Sales Growth 22.71% 23.05% 19.56% 23.58% -6.34% -17.55% -9.40% -14.72% -14.10% -49.35% Cost Of Goods Sold 522.64 484.46 384.62 314.07 229.27 200.31 278.16 330.87 367.46 419.31 781.33 Gross Profit 358.21 334.91 281.28 242.90 221.42 280.90 305.49 313.30 387.89 460.03 954.86 GP Margin 40.67% 40.87% 42.24% 43.61% 49.13% 58.37% 52.34% 48.64% 51.35% 52.32% 55.00% Total Expenditure 759.08 708.57 581.60 498.27 391.92 531.19 589.95 621.96 663.28 705.28 1,416.33 Power & Fuel Cost - 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 102.19 % Of Sales - 7.68% 9.20% 9.47% 8.72% 9.86% 8.35% 7.87% 7.19% 6.29% 5.89% Employee Cost - 69.64 65.35 60.21 64.40 71.60 79.14 82.39 75.44 82.63 185.79 % Of Sales - 8.50% 9.81% 10.81% 14.29% 14.88% 13.56% 12.79% 9.99% 9.40% 10.70% Manufacturing Exp. - 39.75 35.55 32.88 29.09 50.71 54.64 63.08 85.12 91.48 182.20 % Of Sales - 4.85% 5.34% 5.90% 6.45% 10.54% 9.36% 9.79% 11.27% 10.40% 10.49% General & Admin Exp. - 22.22 14.26 10.80 15.23 42.43 28.21 38.52 38.42 28.04 88.13 % Of Sales - 2.71% 2.14% 1.94% 3.38% 8.82% 4.83% 5.98% 5.09% 3.19% 5.08% Selling & Distn. Exp. - 23.86 14.34 20.35 11.52 6.42 7.40 14.62 35.43 21.35 48.59 % Of Sales - 2.91% 2.15% 3.65% 2.56% 1.33% 1.27% 2.27% 4.69% 2.43% 2.80% Miscellaneous Exp. - 5.72 6.22 7.22 3.10 112.29 93.64 41.79 7.07 7.19 48.59 % Of Sales - 0.70% 0.93% 1.30% 0.69% 23.33% 16.04% 6.49% 0.94% 0.82% 1.62% EBITDA 121.79 110.80 84.30 58.70 58.77 -49.98 -6.30 22.21 92.08 174.06 319.86 EBITDA Margin 13.83% 13.52% 12.66% 10.54% 13.04% -10.39% -1.08% 3.45% 12.19% 19.79% 18.42% Other Income 36.27 30.65 19.43 9.00 6.46 24.28 16.93 19.87 19.48 24.60 42.37 Interest 14.26 16.71 32.90 33.46 52.21 6.22 6.68 310.25 331.10 294.23 537.01 Depreciation 33.95 33.22 54.79 87.02 108.90 117.91 129.92 133.29 139.42 143.41 321.37 PBT 109.84 91.52 16.04 -52.77 -95.87 -149.84 -125.99 -401.47 -358.96 -238.98 -496.15 Tax -3.23 -3.23 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 -191.75 Tax Rate -2.94% -3.53% 0.00% 0.00% 0.00% 0.00% 0.00% 11.51% 9.04% 5.92% 50.09% PAT 113.07 94.75 55.25 -52.77 -95.87 -149.84 -101.05 -355.28 -483.63 -274.27 -191.04 PAT before Minority Interest 113.07 94.75 55.25 -52.77 -95.87 -149.84 -101.05 -355.28 -483.63 -274.27 -191.04 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.84% 11.56% 8.30% -9.47% -21.27% -31.14% -17.31% -55.15% -64.03% -31.19% -11.00% PAT Growth 41.13% 71.49% - - - - - - - - EPS 22.30 18.69 10.90 -10.41 -18.91 -29.55 -19.93 -70.07 -95.39 -54.10 -37.68

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 880.85 819.37 665.90 559.56 450.06 483.80 599.98 682.98 796.50 873.44 1,746.61 Net Sales Growth 22.71% 23.05% 19.00% 24.33% -6.97% -19.36% -12.15% -14.25% -8.81% -49.99% Cost Of Goods Sold 522.64 484.46 384.62 313.56 228.51 203.35 289.70 350.20 393.46 400.96 779.03 Gross Profit 358.21 334.91 281.28 246.00 221.56 280.45 310.28 332.79 403.05 472.47 967.58 GP Margin 40.67% 40.87% 42.24% 43.96% 49.23% 57.97% 51.72% 48.73% 50.60% 54.09% 55.40% Total Expenditure 760.73 708.58 581.60 504.98 399.40 514.99 611.80 658.68 709.37 702.65 1,429.32 Power & Fuel Cost - 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 102.19 % Of Sales - 7.68% 9.20% 9.43% 8.73% 9.81% 8.13% 7.42% 6.82% 6.33% 5.85% Employee Cost - 69.64 65.35 63.28 67.11 74.86 82.28 86.22 80.25 86.81 193.82 % Of Sales - 8.50% 9.81% 11.31% 14.91% 15.47% 13.71% 12.62% 10.08% 9.94% 11.10% Manufacturing Exp. - 39.75 35.55 32.88 29.10 53.25 55.98 65.65 87.40 94.33 182.40 % Of Sales - 4.85% 5.34% 5.88% 6.47% 11.01% 9.33% 9.61% 10.97% 10.80% 10.44% General & Admin Exp. - 22.22 14.26 13.03 18.34 43.67 30.72 41.49 40.99 31.10 91.62 % Of Sales - 2.71% 2.14% 2.33% 4.08% 9.03% 5.12% 6.07% 5.15% 3.56% 5.25% Selling & Distn. Exp. - 23.86 14.34 22.26 13.46 8.14 10.34 22.10 45.73 27.73 51.28 % Of Sales - 2.91% 2.15% 3.98% 2.99% 1.68% 1.72% 3.24% 5.74% 3.17% 2.94% Miscellaneous Exp. - 5.73 6.22 7.22 3.59 84.27 94.02 42.34 7.21 6.44 51.28 % Of Sales - 0.70% 0.93% 1.29% 0.80% 17.42% 15.67% 6.20% 0.91% 0.74% 1.66% EBITDA 120.11 110.79 84.30 54.58 50.66 -31.19 -11.82 24.30 87.13 170.79 317.29 EBITDA Margin 13.64% 13.52% 12.66% 9.75% 11.26% -6.45% -1.97% 3.56% 10.94% 19.55% 18.17% Other Income 36.91 31.13 19.43 9.00 15.21 24.28 16.93 20.30 19.17 24.91 42.47 Interest 14.31 16.74 32.90 33.46 52.21 6.23 6.69 310.26 331.11 294.24 537.12 Depreciation 33.97 33.24 54.79 87.02 108.92 117.93 129.94 133.31 141.02 145.27 324.58 PBT 108.71 91.95 16.04 -56.90 -95.25 -131.07 -131.52 -398.96 -365.82 -243.82 -501.95 Tax -3.27 -3.12 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 -191.46 Tax Rate -3.01% -3.39% 0.00% 0.00% 0.00% 0.00% 0.00% 11.58% 8.92% 5.82% 49.27% PAT 111.98 95.06 55.25 -56.90 -95.25 -131.07 69.41 -352.77 -490.49 -279.11 -196.51 PAT before Minority Interest 111.98 95.06 55.25 -56.90 -95.25 -131.07 69.41 -352.77 -490.49 -279.11 -197.13 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.62 PAT Margin 12.71% 11.60% 8.30% -10.17% -21.16% -27.09% 11.57% -51.65% -61.58% -31.96% -11.25% PAT Growth 39.77% 72.05% - - - - - - - - EPS 22.09 18.75 10.90 -11.22 -18.79 -25.85 13.69 -69.58 -96.74 -55.05 -38.76

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,218.32 731.96 677.95 681.34 797.83 -754.99 -674.13 -263.83 171.13 439.40 Share Capital 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 85.26 Total Reserves 1,167.60 691.15 637.14 640.52 757.01 -843.95 -763.10 -352.80 82.17 354.14 Non-Current Liabilities 124.21 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 2,609.53 Secured Loans 0.00 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 2,493.95 Unsecured Loans 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 4.18 Current Liabilities 209.67 326.63 193.83 100.87 133.18 2,312.71 1,980.28 1,519.64 1,315.98 1,107.10 Trade Payables 179.39 129.11 120.74 68.74 60.21 269.93 326.85 403.68 353.09 295.85 Other Current Liabilities 14.15 53.09 47.25 25.76 69.72 1,343.66 958.10 476.00 285.05 112.37 Short Term Borrowings 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.62 646.64 Short Term Provisions 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 52.23 Total Liabilities 1,552.20 1,223.26 1,094.18 1,224.47 1,449.99 2,993.25 3,210.77 3,460.76 3,962.52 4,156.03 Net Block 616.43 573.06 583.65 670.39 857.86 1,161.35 1,291.28 1,401.71 1,540.36 1,697.10 Gross Block 1,297.02 1,220.45 1,176.26 1,175.97 1,246.98 1,424.57 1,424.57 2,893.25 2,893.19 2,889.70 Accumulated Depreciation 680.59 647.39 592.60 505.58 389.12 263.22 133.29 1,491.54 1,352.83 1,192.60 Non Current Assets 769.91 729.46 711.12 682.22 885.22 2,209.79 2,519.97 2,507.72 2,638.40 2,809.23 Capital Work in Progress 24.46 46.09 9.78 7.43 25.61 278.16 271.53 288.31 280.40 281.51 Non Current Investment 69.40 50.12 49.01 0.40 0.34 0.47 124.77 124.66 124.65 124.65 Long Term Loans & Adv. 59.61 60.20 68.66 3.98 1.41 759.97 822.41 685.17 680.99 681.85 Other Non Current Assets 0.02 0.00 0.01 0.01 0.00 9.84 9.98 7.88 12.00 24.12 Current Assets 782.29 493.79 369.78 542.25 564.77 783.46 690.80 953.03 1,324.12 1,346.79 Current Investments 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 264.23 228.74 172.66 150.57 140.78 167.11 184.94 197.45 210.34 242.28 Sundry Debtors 189.37 211.91 160.23 131.96 66.38 140.73 145.06 246.42 375.44 290.16 Cash & Bank 257.23 22.34 4.21 18.97 172.32 324.17 301.04 256.04 313.11 389.57 Other Current Assets 71.47 3.64 12.86 130.11 185.29 151.45 59.75 253.12 425.23 424.78 Short Term Loans & Adv. 64.67 27.17 19.83 95.63 163.95 127.86 40.31 244.22 308.82 319.26 Net Current Assets 572.62 167.16 175.95 441.38 431.59 -1,529.25 -1,289.49 -566.61 8.14 239.69 Total Assets 1,552.20 1,223.25 1,080.90 1,224.47 1,449.99 2,993.25 3,210.77 3,460.75 3,962.52 4,156.02

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,169.47 688.65 647.38 652.91 765.98 -704.04 -791.76 -387.67 49.04 329.39 Share Capital 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 85.26 Total Reserves 1,118.75 647.83 606.56 612.09 725.17 -793.00 -880.72 -476.63 -39.92 244.12 Non-Current Liabilities 124.43 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 2,609.35 Secured Loans 0.22 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 2,493.95 Unsecured Loans 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 4.18 Current Liabilities 259.97 371.89 240.78 142.08 174.94 2,345.54 2,012.51 1,540.72 1,337.62 1,122.66 Trade Payables 229.58 174.37 167.68 109.95 101.59 302.45 358.79 424.52 374.27 311.15 Other Current Liabilities 14.27 53.09 47.25 25.76 70.10 1,343.97 958.40 476.24 285.34 112.64 Short Term Borrowings 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.79 646.64 Short Term Provisions 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 52.23 Total Liabilities 1,553.87 1,225.21 1,110.56 1,237.25 1,459.90 3,077.03 3,125.37 3,358.00 3,862.07 4,061.40 Net Block 620.23 573.09 583.70 670.45 857.93 1,256.26 1,386.20 1,496.54 1,636.83 1,795.20 Gross Block 1,300.94 1,220.56 1,176.39 1,176.10 1,247.11 1,519.52 1,519.16 3,005.92 3,005.87 3,002.15 Accumulated Depreciation 680.71 647.47 592.68 505.66 389.18 263.26 132.96 1,509.38 1,369.04 1,206.95 Non Current Assets 763.12 724.20 712.91 687.39 890.58 2,309.57 2,446.42 2,478.86 2,610.87 2,783.27 Capital Work in Progress 30.67 46.46 9.78 7.43 25.61 278.16 271.53 288.31 280.40 281.51 Non Current Investment 45.82 44.44 45.49 0.40 0.34 0.47 1.07 0.96 0.81 0.81 Long Term Loans & Adv. 66.38 60.20 73.93 9.10 6.70 764.84 777.64 685.17 680.83 681.63 Other Non Current Assets 0.02 0.00 0.01 0.01 0.00 9.84 9.98 7.88 12.00 24.12 Current Assets 790.75 501.01 384.36 549.86 569.32 767.46 678.94 879.14 1,251.20 1,278.12 Current Investments 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 264.23 228.74 172.66 152.89 141.69 169.77 193.74 211.25 241.85 251.93 Sundry Debtors 195.55 215.19 170.57 135.70 67.97 119.89 119.51 203.00 310.07 256.57 Cash & Bank 266.57 30.63 8.06 19.91 174.04 325.52 305.55 257.06 314.94 390.56 Other Current Assets 64.41 3.95 13.01 130.47 185.62 152.28 60.14 207.82 384.34 379.06 Short Term Loans & Adv. 57.39 22.50 20.07 95.87 164.05 140.27 40.31 198.36 267.62 273.26 Net Current Assets 530.78 129.12 143.58 407.78 394.39 -1,578.08 -1,333.57 -661.58 -86.42 155.46 Total Assets 1,553.87 1,225.21 1,097.27 1,237.25 1,459.90 3,077.03 3,125.36 3,358.00 3,862.07 4,061.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 130.73 13.39 89.57 24.36 80.42 15.18 5.58 317.68 211.30 -369.72 PBT 91.52 54.19 -4.81 -117.15 -149.84 -101.05 -401.47 -445.42 -291.52 -237.53 Adjustment 41.68 54.10 38.24 163.69 174.58 235.19 449.77 575.53 495.56 999.29 Changes in Working Capital -3.22 -94.60 58.04 -27.10 45.25 -114.68 -35.68 187.56 7.26 -668.57 Cash after chg. in Working capital 129.99 13.69 91.47 19.44 70.00 19.46 12.62 317.68 211.30 93.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.74 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 -47.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -415.87 Cash From Investing Activity -315.81 -26.70 112.93 67.21 167.12 45.48 -27.95 -8.62 -1.23 1,334.21 Net Fixed Assets -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 848.92 Net Investments -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 -0.47 Others -241.59 54.91 149.16 -6.90 -263.15 -72.19 -1,513.30 -0.64 1.15 485.76 Cash from Financing Activity 167.07 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.12 -286.52 -597.32 Net Cash Inflow / Outflow -18.01 17.86 -14.30 -73.42 -2.79 60.36 11.02 -57.07 -76.45 367.17 Opening Cash & Equivalents 18.31 0.45 14.75 88.17 90.97 30.60 19.58 313.11 389.57 22.40 Closing Cash & Equivalent 0.29 18.31 0.45 14.75 88.17 90.97 30.60 256.04 313.11 389.57

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 125.99 18.34 92.47 23.59 80.80 12.02 9.18 317.01 212.20 -369.07 PBT 89.05 46.32 -1.95 -116.53 -131.07 69.41 -398.96 -452.28 -296.18 -243.29 Adjustment 44.15 51.38 36.77 172.15 139.57 57.34 453.49 582.11 490.19 1,006.39 Changes in Working Capital -7.84 -79.06 59.57 -36.96 61.89 -110.44 -38.31 187.17 18.19 -669.27 Cash after chg. in Working capital 125.36 18.64 94.38 18.66 70.38 16.30 16.22 317.01 212.20 93.84 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.63 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 -47.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -415.87 Cash From Investing Activity -312.03 -31.21 112.94 67.21 167.11 45.47 -28.06 -8.59 -1.46 1,333.66 Net Fixed Assets -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 848.92 Net Investments -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 -0.47 Others -237.81 50.40 149.17 -6.90 -263.16 -72.20 -1,513.41 -0.61 0.92 485.21 Cash from Financing Activity 167.04 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.30 -286.36 -597.44 Net Cash Inflow / Outflow -19.00 18.29 -11.39 -74.20 -2.42 57.20 14.51 -57.88 -75.62 367.14 Opening Cash & Equivalents 22.60 4.31 15.69 89.89 92.31 35.11 20.60 314.94 390.56 23.42 Closing Cash & Equivalent 3.60 22.60 4.31 15.69 89.89 92.31 35.11 257.06 314.94 390.56

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 240.21 179.33 166.10 166.93 195.47 -84.86 -75.78 -29.66 19.24 51.54 ROA 6.83% 4.77% -4.55% -7.17% -6.74% -3.26% -10.65% -13.03% -6.76% -4.30% ROE 9.72% 7.84% -7.76% -12.96% -699.60% 0.00% 0.00% 0.00% -89.85% -41.19% ROCE 8.96% 8.77% -1.86% -3.50% -7.48% -3.77% -3.40% -6.44% 0.08% 4.20% Fixed Asset Turnover 0.65 0.56 0.47 0.37 0.36 0.41 0.30 0.26 0.31 0.53 Receivable days 89.38 101.99 95.74 80.31 78.55 89.36 110.08 148.10 136.50 49.54 Inventory Days 109.80 110.01 105.91 117.98 116.77 110.08 107.53 97.12 92.83 77.61 Payable days 116.21 118.55 110.10 102.64 113.51 182.54 192.92 181.33 144.12 82.15 Cash Conversion Cycle 82.96 93.45 91.55 95.64 81.81 16.91 24.69 63.90 85.21 45.00 Total Debt/Equity 0.11 0.45 0.40 0.66 0.71 -4.28 -4.75 -11.77 18.78 7.31 Interest Cover 6.48 2.68 -0.58 -0.84 -23.07 -14.12 -0.29 -0.61 0.01 0.29

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 230.58 168.72 158.61 159.96 187.67 -79.14 -89.00 -43.58 5.51 38.63 ROA 6.84% 4.73% -4.85% -7.06% -5.78% 2.24% -10.88% -13.59% -7.05% -4.53% ROE 10.23% 8.27% -8.75% -13.43% -423.17% 0.00% 0.00% 0.00% -147.51% -55.58% ROCE 9.35% 9.11% -2.32% -3.53% -6.47% 3.08% -3.46% -6.93% -0.06% 4.17% Fixed Asset Turnover 0.65 0.56 0.48 0.37 0.35 0.39 0.30 0.27 0.29 0.52 Receivable days 91.49 105.72 99.89 82.59 70.86 72.82 85.57 115.97 116.98 45.27 Inventory Days 109.80 110.01 106.18 119.45 117.49 110.57 107.46 102.41 101.94 78.79 Payable days 152.17 162.30 161.59 168.95 136.49 197.80 198.57 186.30 148.72 86.46 Cash Conversion Cycle 49.12 53.43 44.47 33.09 51.86 -14.40 -5.54 32.07 70.20 37.60 Total Debt/Equity 0.12 0.48 0.41 0.69 0.74 -4.59 -4.04 -8.01 65.54 9.75 Interest Cover 6.49 2.68 -0.70 -0.82 -20.04 11.38 -0.29 -0.63 -0.01 0.28

Top Investors:

quant mutual fund - quant small cap fund

invesco india esg integration strategy fund, invesco india contra fund and 5 others names

nippon life india trustee ltd-a/c nippon india pharma fund

jm financial mutual fund - jm small cap fund and 7 others

Annual Reports:

News Update:

Orchid Pharma - Quarterly Results
12th Aug 2024, 19:29 PM

Read More
Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India
28th Jun 2024, 16:14 PM

This collaboration will set a new benchmark for addressing critical healthcare challenges through strategic partnerships and advanced research
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback